Esperion Therapeutics, Inc. (ESPR)

2.72 -0.05 (-1.81%) USD  |  NASDAQ  |  Mar 06, 16:00
2.725 0.00 (0.00%) After-Hours: 20:00
More

Esperion Therapeutics Income Tax Paid Supplemental Data (Annual)

Income Tax Paid Supplemental Data (Annual) Chart

View Income Tax Paid Supplemental Data (Annual) for ESPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Income Tax Paid Supplemental Data (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Income Tax Paid Supplemental Data (Annual) Range, Past 5 Years

View Income Tax Paid Supplemental Data (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Income Tax Paid Supplemental Data (Annual) Benchmarks

View Income Tax Paid Supplemental Data (Annual) Benchmarks
Start Trial
Harrow, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Nektar Therapeutics Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
AnaptysBio, Inc. Upgrade